Transition Therapeutics (Ireland 2) Limited
Equity
€-4.9M
Total equity, calculated from disclosed equity components.
Net Profit
€-40K
Period result as reported on the balance sheet. Income statement not separately filed.
Return on equity
Not meaningful — negative equity
Registered address
26, boulevard de Kockelscheuer, L-1821 Luxembourg
Activity (NACE 64.202)
Financial holdings ("Soparfi")
Constituted
1 January 0001
Registered
12 November 2018
Establishment number
B229143.0
Financials
Abridged Balance Sheet only · eCDF
| 2019 | 2018 | |
|---|---|---|
| Net income | €-40K | €-1.6M |
| Equity | €-4.9M | €-4.9M |
| Total assets | — | €152K |
Establishments
- Transition Therapeutics (Ireland 2) Limited principal 26, boulevard de Kockelscheuer, L-1821, Luxembourg
Filings
-
Deletion
- 10 May 2024 -
Modification
Voluntary liquidation 8 June 2023 -
Statutory/non-statutory modification without registration
- 26 April 2023 -
Annual accounts (eCDF)
Exercise from 01/01/2018 to 31/12/2018 18 July 2022 -
Annual accounts (eCDF)
Exercise from 01/01/2019 to 31/12/2019 18 July 2022 -
Articles of association
- 9 April 2020 -
Modification
Voluntary liquidation 20 March 2020 -
Modification
Social capital/social funds Associate(s) 21 February 2020 -
Modification
Registered office 26 June 2019 -
Registration
- 12 November 2018
Full credit report
Ratios, peer benchmarks, risk scoring and a downloadable PDF for Transition Therapeutics (Ireland 2) Limited.